Nuclear export inhibitors avert progression in preclinical models of inflammatory demyelinationJeffery D. Haines, Patrizia Casaccia, Olivier Herbin et al.|Nature Neuroscience|2015Cited by 97
In silico screening and preclinical validation identify bavisant as a therapeutic candidate for multiple sclerosisNadjet Gacem, Gianvito Martino, Linda K Ottoboni et al.|Science Translational Medicine|2026Cited by 3